Zurich Cantonal Bank
LJPC

Zurich Cantonal Bank’s La Jolla Pharmaceutical Company LJPC Stock Holding History

Zurich Cantonal Bank’s Portfolio LJPC Stock Details LJPC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-2,117
Closed -$14K – 2677
2019
Q1 		$14K Hold
2,117
– – ﹤0.01% 2488
2018
Q4 		$20K Hold
2,117
– – ﹤0.01% 2458
2018
Q3 		$43K Hold
2,117
– – ﹤0.01% 2236
2018
Q2 		$62K Hold
2,117
– – ﹤0.01% 1987
2018
Q1 		$63K Hold
2,117
– – ﹤0.01% 1906
2017
Q4 		$68K Buy
2,117
+594
+39% +$19.4K ﹤0.01% 1833
2017
Q3 		$53K Hold
1,523
– – ﹤0.01% 1771
2017
Q2 		$45K Buy
+1,523
New +$43.6K ﹤0.01% 1840

Other funds holding LJPC

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
VMI
VHCP Management III New York $504M AUM 683.12% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Zurich Cantonal Bank's LJPC Position: Q2 2019 in Review

Zurich Cantonal Bank sold out of La Jolla Pharmaceutical Company (LJPC) in Q2 2019, closing a stake of 2,117 shares — an estimated $14K sold.

Zurich Cantonal Bank first reported a position in LJPC in Q2 2017 and held it in 8 quarters. The position peaked at $68K in Q4 2017. 80 funds tracked by Wall St. Rank hold LJPC as of Q2 2019.

  • Zurich Cantonal Bank reported no remaining La Jolla Pharmaceutical Company position as of Q2 2019 after selling out during the quarter.
  • Zurich Cantonal Bank sold 2,117 La Jolla Pharmaceutical Company shares in Q2 2019, an estimated $14K.
  • Zurich Cantonal Bank first reported a position in La Jolla Pharmaceutical Company in Q2 2017 and held it in 8 quarters.
  • Zurich Cantonal Bank's La Jolla Pharmaceutical Company position peaked at $68K in Q4 2017.
  • 80 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q2 2019.

Based on Zurich Cantonal Bank's 13F filing for Q2 2019, filed 30 Jul 2019.